MedTrace Logo

Fluorescence Surgery for Sentinel Node Identification in Melanoma

NCT02142244 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2017-02-02

No results posted yet for this study

Summary

Sentinel node biopsy is a surgical procedure used to find melanoma lymph node metastasis (i.e. groin/axilla) in very early stages. This study aims to add a new technology over the standard procedure - a fluorescent contrast (indocyanine green) using special light (near infra-red) - looking for more precise diagnosis of the presence of the lymph node metastasis.

Conditions

Interventions

PROCEDURE

Near infra red sentinel node biopsy

Explicated in the protocol arm

DRUG

Indocyanine green

Explicated in the protocol arm

DEVICE

Intraoperative Near-Infrared Imaging System

Explicated in the protocol arm

Sponsors & Collaborators

  • Barretos Cancer Hospital

    lead OTHER

Principal Investigators

  • Vinicius L Vazquez, Ph.D. · Barretos Cancer Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2018-12-31
Completion
2021-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02142244 on ClinicalTrials.gov